A path-analytical approach to differentiate between direct and indirect drug effects on negative symptoms in schizophrenic patients. A re-evaluation of the North American risperidone study.

Source:http://linkedlifedata.com/resource/pubmed/id/7540426

Download in:

View as

General Info

PMID
7540426